Volume 26, Number 9—September 2020
Research
Heterogeneity of Dengue Illness in Community-Based Prospective Study, Iquitos, Peru
Table 2
Symptom | Odds ratio (95% CI)* | Δ-AIC† |
---|---|---|
Malaise | 1.36 (1.25–1.48) | 42.1 |
Weakness | 1.48 (1.36–1.63) | 35.8 |
Fever | 1.28 (1.19–1.38) | 20.8 |
Abdominal | 1.34 (1.22–1.48) | 9.9 |
Body pain | 1.32 (1.22–1.43) | 9.1 |
Headache | 1.27 (1.17–1.37) | 9.0 |
Chills | 1.31 (1.21–1.43) | 3.3 |
Muscle pain | 1.25 (1.15–1.35) | 2.7 |
Joint pain | 1.23 (1.13–1.34) | −0.0 |
Retroorbital pain | 1.11 (1.03–1.2) | −0.1 |
Sore throat | 1.02 (0.87–1.18) | −0.5 |
Bone pain | 1.24 (1.15–1.36) | −1.4 |
*Shown is the increase in odds of reporting a major activity change when symptom intensity is increased by 1 point for each of the 12 symptoms.
†Δ-AIC, difference in Akaike Information Criteria between models by using binary symptom presence versus symptom intensity (0–10) as a predictor of major activity change. A positive Δ-AIC favors the use of intensity over presence of symptom alone.
Page created: June 03, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.